Day: October 4, 2023

VS Media Expands into Macau, Demonstrating Strong Growth and Extensive Experience in Digital Marketing

Written by Customer Service on October 4, 2023. Posted in Public Companies.

HONG KONG, Oct. 04, 2023 (GLOBE NEWSWIRE) — VS Media Holdings Limited (NASDAQ: VSME), a leader in managing a global network of digital creators, is excited to announce its expansion into Macau, further solidifying its presence in the Asian market. With a decade-long track record of success operating in Hong Kong and Taiwan, VS Media is well-positioned to bring its extensive capabilities and expertise to Macau’s thriving tourism and hospitality industry. The strategic move into Macau allows VS Media to leverage its vast experience in digital marketing, influencer engagement, and content creation to support Macau businesses in promoting their offerings to a global audience. With a robust network of talented content creators, VS Media consistently delivers impactful campaigns that resonate with target audiences, driving brand...

Correction: Form 8.3 – Renewi PLC

Written by Customer Service on October 4, 2023. Posted in Public Companies.

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Renewi PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure,...

China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split

Written by Customer Service on October 4, 2023. Posted in Public Companies.

Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on October 5, 2023 TAIZHOU, China, Oct. 04, 2023 (GLOBE NEWSWIRE) — China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that its Board of Directors has set the date of October 5, 2023 to be the effective date for the Company’s one-for-twenty-five reverse stock split of its issued and outstanding ordinary shares. The Company’s ordinary shares will begin trading on the NASDAQ Stock Market...

AgriFORCE Invests in Radical Clean Solutions’ Innovative Food Safety Technology

Written by Customer Service on October 4, 2023. Posted in Public Companies.

Proprietary system seeks out and destroys airborne and surface-based mold, bacteria, viruses and other pathogens in real-time Food contamination costs the US Economy over $18 billions of dollars per year(1) Hydroxyl technology is capable of destroying E. coli, Salmonella, as well as other bacteria and other pathogens that present risk to consumers VANCOUVER, British Columbia, Oct. 04, 2023 (GLOBE NEWSWIRE) — AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (IP)-focused AgTech company, today announced it has purchased a 14% stake in Radical Clean Solutions (“RCS”). RCS, under the leadership of Roger Slotkin, has developed and is commercializing a suite of proprietary and patent-pending chemical-free Hydroxyl devices that are proven to eliminate pathogens, mold, mildew and VOCs in food...

Kineta Presents New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy

Written by Customer Service on October 4, 2023. Posted in Public Companies.

Preclinical data highlights CD27’s mechanism of action and strong anti-tumor activity as a monotherapy and in combination with other checkpoint inhibitors SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today the presentation of new preclinical data on the company’s anti-CD27 agonist monoclonal antibodies (mAbs) in development for the treatment of advanced solid tumors at the American Association for Cancer Research (AACR) Special Conference on Tumor Immunology and Immunotherapy. Thierry Guillaudeux, Ph.D., Chief Scientific Officer of Kineta, unveiled new preclinical data in the company’s poster titled “CD27 is a new promising T cell co-stimulatory target for...

Femasys Inc. to Showcase FemaSeed at the Annual Meeting of the American Society of Reproductive Medicine

Written by Customer Service on October 4, 2023. Posted in Public Companies.

ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced that it will be exhibiting at the annual meeting of the American Society of Reproductive Medicine (ASRM): “The Past, The Present, and The Pipeline”, being held in New Orleans, Louisiana from October 14-18, 2023. Femasys will be showcasing its reproductive portfolio, including FemaSeed®, an innovative infertility treatment designed to deliver sperm directly to where conception occurs in a woman’s fallopian tube that recently received 510(k) clearance from the United States Food and Drug Administration (FDA) allowing...

Lincoln Educational Services Advances Plans to Relocate its Philadelphia Campus to Levittown, PA and Expand its Program Offerings

Written by Customer Service on October 4, 2023. Posted in Public Companies.

The new larger facility will provide three new career training programs – Welding Technology, HVAC and Electrical and Electronic Systems Technology (EEST) – in addition to the Automotive Technology program offered at the current Philadelphia campus. Parsippany, NJ, Oct. 04, 2023 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training for more than 75 years, has purchased the 90,000 square foot property located at 311 Veterans Highway, Levittown, PA for approximately $10 million. The Company also expects to invest approximately $12 million in the buildout of new classrooms and training areas to ensure a best-in-class campus that provides a positive experience for students, faculty and industry partners. Furthermore, the Company plans to sell the property by...

North American Construction Group Closes Acquisition of MacKellar Group and Establishes Transition Team

Written by Customer Service on October 4, 2023. Posted in Mergers And Acquisitions.

ACHESON, Alberta, Oct. 04, 2023 (GLOBE NEWSWIRE) — North American Construction Group Ltd. (“NACG” or the “Company”) (TSX:NOA) today announced the closing of its acquisition of MacKellar Group (“MacKellar”), with an effective date of October 1, 2023. Total expected consideration is $395 million (the “Consideration”), with the final Consideration amount to be determined based on MacKellar’s audited financial statements as of September 30, 2023, which will be reflected in the Company’s financial statements for the year ending December 31, 2023. The Transaction was previously announced on July 26, 2023. Concurrent with closing of the transaction (“Closing”), the Company entered into an amended and restated senior revolving credit facility (the “Credit Facility”) with an upsized overall lending capacity of $430 million provided by Canadian...

New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeutics

Written by Customer Service on October 4, 2023. Posted in Mergers And Acquisitions.

This acquisition expands Comprehensive Cell Solutions, a business unit of NYBCe, capabilities and geographic reach as a commercial-scale cell therapy clinical development and manufacturing organization NEW YORK and BOSTON, Oct. 04, 2023 (GLOBE NEWSWIRE) — New York Blood Center Enterprises (NYBCe) and Talaris Therapeutics, Inc. (Nasdaq: TALS) (“Talaris”) announced today NYBCe’s acquisition of commercial-scale cell and gene therapy development and manufacturing facilities, as well as certain technologies and equipment from Talaris in Houston, Texas and Louisville, Kentucky. The acquisition of both locations, combined with NYBCe’s Comprehensive Cell Solutions (CCS) vast cell sourcing and collection network, accelerates the delivery of a fully integrated vein-to-vein cell and gene therapy development and manufacturing solution for...

Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation

Written by Customer Service on October 4, 2023. Posted in Public Companies.

ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will participate in the Society for Cardiac Robotic Navigation’s 7th Annual Meeting, which will take place October 19-20 in Washington, DC. The global physician-led Society for Cardiac Robotic Navigation (SCRN) is dedicated to establishing a community and platform for users of robotic technologies in cardiology. The annual SCRN conference provides a venue for physicians and healthcare professionals to share best practices, discuss new clinical literature, and evaluate the latest innovations in technology. The program includes a broad range of presentations, panels, and demonstrations on the use of Stereotaxis’ robotic technologies with topics...

Day: October 4, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice